share_log

Community Health Sys Analyst Ratings

Community Health Sys Analyst Ratings

社區健康系統分析師評級
Benzinga ·  2023/10/30 13:33
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
10/30/2023 189.86% RBC Capital $7 → $6 Maintains Outperform
10/20/2023 44.93% Wells Fargo $5 → $3 Maintains Equal-Weight
10/11/2023 69.08% Truist Securities $5 → $3.5 Maintains Hold
08/07/2023 214.01% Oppenheimer → $6.5 Reiterates Outperform → Outperform
06/20/2023 141.55% Truist Securities $4.5 → $5 Maintains Hold
05/03/2023 238.16% Citigroup $9 → $7 Maintains Buy
05/03/2023 238.16% RBC Capital $11 → $7 Maintains Outperform
05/03/2023 141.55% Wells Fargo $8 → $5 Maintains Equal-Weight
05/03/2023 257.49% Credit Suisse $8.5 → $7.4 Maintains Neutral
05/02/2023 214.01% Oppenheimer → $6.5 Reiterates → Outperform
02/17/2023 310.63% Credit Suisse $3.3 → $8.5 Maintains Neutral
01/19/2023 165.7% Oppenheimer $5 → $5.5 Maintains Outperform
01/03/2023 117.39% Wells Fargo $3 → $4.5 Maintains Equal-Weight
11/23/2022 59.42% Credit Suisse $4 → $3.3 Maintains Neutral
08/01/2022 214.01% Credit Suisse $8 → $6.5 Maintains Neutral
07/29/2022 189.86% Oppenheimer $16 → $6 Maintains Outperform
06/17/2022 141.55% Loop Capital → $5 Initiates Coverage On → Hold
06/15/2022 165.7% B of A Securities $7.5 → $5.5 Downgrades Buy → Neutral
05/02/2022 310.63% Wells Fargo $12 → $8.5 Maintains Equal-Weight
04/29/2022 576.33% Citigroup $18 → $14 Maintains Buy
04/29/2022 817.87% RBC Capital $21 → $19 Maintains Outperform
03/29/2022 479.71% Wells Fargo → $12 Initiates Coverage On → Equal-Weight
12/13/2021 672.95% B of A Securities $14 → $16 Upgrades Underperform → Buy
10/29/2021 600.48% Credit Suisse $12 → $14.5 Maintains Neutral
09/24/2021 503.86% UBS → $12.5 Initiates Coverage On → Neutral
08/03/2021 383.09% Barclays $6 → $10 Maintains Underweight
07/30/2021 479.71% Credit Suisse $10 → $12 Maintains Neutral
07/09/2021 Seaport Global Initiates Coverage On → Neutral
06/10/2021 914.49% RBC Capital $12 → $21 Upgrades Sector Perform → Outperform
05/05/2021 769.57% Jefferies $11 → $18 Upgrades Hold → Buy
04/30/2021 383.09% Credit Suisse $4.1 → $10 Upgrades Underperform → Neutral
02/19/2021 98.07% Credit Suisse $3.5 → $4.1 Maintains Underperform
05/04/2020 238.16% Oppenheimer $8 → $7 Maintains Outperform
02/20/2020 93.24% B of A Securities $3.5 → $4 Maintains Underperform
02/20/2020 Raymond James Upgrades Underperform → Market Perform
12/18/2019 69.08% SunTrust Robinson Humphrey $4 → $3.5 Maintains Hold
10/31/2018 93.24% Cantor Fitzgerald $6 → $4 Maintains Neutral
日期 上行/下行 分析公司 目標價格變化 評級變化 上一次/當前評級
2023年10月30日 189.86% 加拿大皇家銀行資本 $7→$6 維護 跑贏大盤
10/20/2023 44.93% 富國銀行 $5→$3 維護 等重
2023年10月11日 69.08% Truist證券 $5→$3.5 維護 保持
08/07/2023 214.01% 奧本海默 →$6.5 重申 跑贏→跑贏大盤
06/20/2023 141.55% Truist證券 $4.5→$5 維護 保持
05/03/2023 238.16% 花旗集團 $9→$7 維護
05/03/2023 238.16% 加拿大皇家銀行資本 $11→$7 維護 跑贏大盤
05/03/2023 141.55% 富國銀行 $8→$5 維護 等重
05/03/2023 257.49% 瑞士信貸 $8.5→$7.4 維護 中性
05/02/2023 214.01% 奧本海默 →$6.5 重申 →跑贏大盤
02/17/2023 310.63% 瑞士信貸 $3.3→$8.5 維護 中性
2023年1月19日 165.7% 奧本海默 $5→$5.5 維護 跑贏大盤
01/03/2023 117.39% 富國銀行 $3→$4.5 維護 等重
2022年11月23日 59.42% 瑞士信貸 $4→$3.3 維護 中性
08/01/2022 214.01% 瑞士信貸 $8→$6.5 維護 中性
07/29/2022 189.86% 奧本海默 $16→$6 維護 跑贏大盤
06/17/2022 141.55% 環路資本 →$5 開始承保 →保留
2022/06/15 165.7% B of A證券 $7.5→$5.5 評級下調 購買→中性
05/02/2022 310.63% 富國銀行 $12→$8.5 維護 等重
04/29/2022 576.33% 花旗集團 $18→$14 維護
04/29/2022 817.87% 加拿大皇家銀行資本 $21→$19 維護 跑贏大盤
03/29/2022 479.71% 富國銀行 →$12 開始承保 →等重
2021年12月13日 672.95% B of A證券 $14→$16 升級 表現不佳的→收購
10/29/2021 600.48% 瑞士信貸 $12→$14.5 維護 中性
09/24/2021 503.86% 瑞銀集團 →$12.5 開始承保 →中性
08/03/2021 383.09% 巴克萊 $6→$10 維護 體重不足
07/30/2021 479.71% 瑞士信貸 $10→$12 維護 中性
07/09/2021 - 環球海港 開始承保 →中性
2021/10/06 914.49% 加拿大皇家銀行資本 $12→$21 升級 行業表現優於→
05/05/2021 769.57% 傑富瑞 $11→$18 升級 持有→購買
04/30/2021 383.09% 瑞士信貸 $4.1→$10 升級 表現不佳的→中性
02/19/2021 98.07% 瑞士信貸 $3.5→$4.1 維護 表現不佳
05/04/2020 238.16% 奧本海默 $8→$7 維護 跑贏大盤
02/20/2020 93.24% B of A證券 $3.5→$4 維護 表現不佳
02/20/2020 - 雷蒙德·詹姆斯 升級 表現遜於→市場表現
2019年12月18日 69.08% SunTrust Robinson Humphrey $4→$3.5 維護 保持
2018年10月31日 93.24% 康託·菲茨傑拉德 $6→$4 維護 中性

What is the target price for Community Health Sys (CYH)?

社區衛生系統(CYH)的目標價格是多少?

The latest price target for Community Health Sys (NYSE: CYH) was reported by RBC Capital on October 30, 2023. The analyst firm set a price target for $6.00 expecting CYH to rise to within 12 months (a possible 189.86% upside). 14 analyst firms have reported ratings in the last year.

RBC Capital於2023年10月30日報道了社區衛生系統(紐約證券交易所代碼:CYH)的最新目標價。這家分析公司將目標價定為6美元,預計Cyh將在12個月內上漲至(可能上漲189.86%)。過去一年,有14家分析公司公佈了評級。

What is the most recent analyst rating for Community Health Sys (CYH)?

社區衛生系統(CYH)的最新分析師評級是多少?

The latest analyst rating for Community Health Sys (NYSE: CYH) was provided by RBC Capital, and Community Health Sys maintained their outperform rating.

RBC Capital提供了對社區健康系統(紐約證券交易所代碼:CYH)的最新分析師評級,社區健康系統保持了其表現優於大盤的評級。

When is the next analyst rating going to be posted or updated for Community Health Sys (CYH)?

社區衛生系統(CYH)的下一次分析師評級將於何時發佈或更新?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Community Health Sys, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Community Health Sys was filed on October 30, 2023 so you should expect the next rating to be made available sometime around October 30, 2024.

分析師在進行了廣泛的研究後得出股票評級,其中包括查閱公共財務報表,與社區衛生系統的高管和客戶交談,以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次,所以你每年應該會得到每家公司每家公司的4個評級。社區衛生系統的上一次評級是在2023年10月30日提交的,所以你應該預計下一次評級將在2024年10月30日左右的某個時候提供。

Is the Analyst Rating Community Health Sys (CYH) correct?

分析師對社區衛生系統(CYH)的評級正確嗎?

While ratings are subjective and will change, the latest Community Health Sys (CYH) rating was a maintained with a price target of $7.00 to $6.00. The current price Community Health Sys (CYH) is trading at is $2.07, which is out of the analyst's predicted range.

雖然評級是主觀的,並將發生變化,但最新的社區衛生系統(CYH)評級保持不變,目標價在7.00美元至6.00美元之間。社區健康系統目前的交易價格為2.07美元,超出了分析師的預測範圍。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論